Mirae Asset Global Investments Co., Ltd.

Filing Details

13F-HR • 2025-03-31
SEC
Report Date
2025-03-31
Filing Date
2025-04-24
Total Holdings
1,827
Total Value
23729973945
Accession Number
0000905148-25-001297
Form Type
13F-HR
CIK
0001569395
Manager Name
Mirae Asset Global Investments Co., Ltd.
Data Enrichment
87% identified
1,585 identified242 unidentified

Holdings

1,827 positions
Manager:
SEC
Search and click to pin securities to the top
Page 74 of 80
Aquestive Therapeutics, Inc.
AQST|03843E104
Shares:
3184(+4.8%)
Value:
$9.6M(-10.1%)
Autolus Therapeutics plc
AUTL|05280R100
Shares:
5790(-13.0%)
Value:
$9.6M(-36.1%)
Esperion Therapeutics, Inc.
ESPR|29664W105
Shares:
6396(-2.6%)
Value:
$9.6M(-35.9%)
Tectonic Therapeutic, Inc.
TECX|878972108
Shares:
500(+1.6%)
Value:
$9.3M(-59.7%)
Alpha Teknova, Inc.
TKNO|02080L102
Shares:
1784(+0.5%)
Value:
$9.3M(-40.0%)
Vanda Pharmaceuticals Inc.
VNDA|921659108
Shares:
1951(+0.4%)
Value:
$9.2M(-2.1%)
ZILLOW GROUP, INC.
ZG|98954M101
Shares:
135(+1.5%)
Value:
$9.1M(-6.2%)
MAXCYTE, INC.
MXCT|57777K106
Shares:
3314(-5.7%)
Value:
$9.0M(-37.7%)
ALUMIS INC.
ALMS|022307102
Shares:
1580(+0.4%)
Value:
$8.9M(-29.8%)
CBL & ASSOCIATES PROPERTIES INC
CBL|124830878
Shares:
332(-3.2%)
Value:
$8.8M(-13.4%)
ACELYRIN, Inc.
SLRN|00445A100
Shares:
3370(+0.8%)
Value:
$8.8M(-19.4%)
OmniAb, Inc.
OABI|68218J103
Shares:
3619(-10.3%)
Value:
$8.8M(-39.5%)
Prime Medicine, Inc.
PRME|74168J101
Shares:
4389(+0.4%)
Value:
$8.7M(-31.1%)
2seventy bio, Inc.
TSVT|901384107
Shares:
1726(+0.4%)
Value:
$8.5M(+63.0%)
Terns Pharmaceuticals, Inc.
TERN|880881107
Shares:
2842(+0.4%)
Value:
$8.3M(-49.2%)
Atea Pharmaceuticals, Inc.
AVIR|04683R106
Shares:
2826(+0.4%)
Value:
$8.3M(-11.7%)
Humacyte, Inc.
HUMA|44486Q103
Shares:
4136(-3.5%)
Value:
$8.1M(-65.6%)
Annexon, Inc.
ANNX|03589W102
Shares:
3567(+0.4%)
Value:
$8.0M(-56.5%)
Design Therapeutics, Inc.
DSGN|25056L103
Shares:
1895(+0.4%)
Value:
$8.0M(-32.4%)
Canaan Inc.
CAN|134748102
Shares:
8708(+6.4%)
Value:
$7.9M(-56.3%)